Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 6/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 13/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 9/20 | 0.37 |
| ▸ | SIRT3 | Q9NTG7 | 6/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16772389 | 0.90 | SELP (0.48) | SELPSIRT2SIRT1SIRT3 | |
| SCHEMBL16772350 | 0.86 | SELP (0.37) | SELPALDH1A1 | |
| SCHEMBL16772369 | 0.82 | SELP (0.35) | SELPALDH1A1 | |
| SCHEMBL14477819 | 0.79 | SELP (0.37) | SELPSIRT2SIRT1SIRT3MEN1 | |
| SCHEMBL14477833 | 0.78 | SELP (0.40) | SELPSIRT2SIRT1SIRT3MEN1 | |
| SCHEMBL20676869 | 0.75 | SELP (0.55) | SELPSIRT2 | |
| SCHEMBL20676825 | 0.75 | SELP (0.55) | SELPSIRT2 | |
| SCHEMBL16933265 | 0.73 | SELP (0.51) | SELPSIRT2SIRT1SIRT3 | |
| SCHEMBL16933268 | 0.73 | SELP (0.51) | SELPSIRT2SIRT1SIRT3 | |
| SCHEMBL26452998 | 0.73 | SELP (0.37) | SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9493497-B2 | Carbamate glycolipid and use thereof | RIKEN (JP) | 2016-11-15 | — | — | US | disclosed |
| US-20150152128-A1 | NEW CARBAMATE GLYCOLIPID AND USE THEREOF | RIKEN (JP) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152128-A1 | NEW CARBAMATE GLYCOLIPID AND USE THEREOF | SGMS1, CD14, SGMS2 | SELP 2028/4885SIRT2 437/4885SIRT1 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.